Literature DB >> 19144788

Safety and immunogenicity of the Mycobacterium tuberculosis DeltalysA DeltapanCD vaccine in domestic cats infected with feline immunodeficiency virus.

Dawn M Zimmerman1, W Ray Waters, Konstantin P Lyashchenko, Brian J Nonnecke, Douglas L Armstrong, William R Jacobs, Michelle H Larsen, Erin Egan, Gregg A Dean.   

Abstract

Feline immunodeficiency virus (FIV)-positive and FIV-negative cats (n=4/group) received 2 x 10(6) CFU Mycobacterium tuberculosis DeltalysA DeltapanCD intramuscularly. Vaccination elicited antibody responses, albeit at lower levels in FIV-positive cats than in FIV-negative cats. Delayed-type hypersensitivity responses were minimal in both groups. No adverse reactions were found.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19144788      PMCID： PMC2650874          DOI： 10.1128/CVI.00396-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  11 in total

1.  A multi-antigen print immunoassay for the development of serological diagnosis of infectious diseases.

Authors:  K P Lyashchenko; M Singh; R Colangeli; M L Gennaro
Journal:  J Immunol Methods       Date:  2000-08-28       Impact factor: 2.303

2.  Animal-side serologic assay for rapid detection of Mycobacterium bovis infection in multiple species of free-ranging wildlife.

Authors:  K P Lyashchenko; R Greenwald; J Esfandiari; M A Chambers; J Vicente; C Gortazar; N Santos; M Correia-Neves; B M Buddle; R Jackson; D J O'Brien; S Schmitt; M V Palmer; R J Delahay; W R Waters
Journal:  Vet Microbiol       Date:  2008-07-07       Impact factor: 3.293

3.  Antibody responses in reindeer (Rangifer tarandus) infected with Mycobacterium bovis.

Authors:  W R Waters; M V Palmer; J P Bannantine; R Greenwald; J Esfandiari; P Andersen; J McNair; J M Pollock; K P Lyashchenko
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

4.  Immune responses to defined antigens of Mycobacterium bovis in cattle experimentally infected with Mycobacterium kansasii.

Authors:  W R Waters; M V Palmer; T C Thacker; J B Payeur; N B Harris; F C Minion; R Greenwald; J Esfandiari; P Andersen; J McNair; J M Pollock; K P Lyashchenko
Journal:  Clin Vaccine Immunol       Date:  2006-06

5.  HspX is present within Mycobacterium paratuberculosis-infected macrophages and is recognized by sera from some infected cattle.

Authors:  J P Bannantine; J R Stabel
Journal:  Vet Microbiol       Date:  2000-10-20       Impact factor: 3.293

6.  The epidemiology of tuberculosis in free-ranging African buffalo (Syncerus caffer) in the Kruger National Park, South Africa.

Authors:  V De Vos; R G Bengis; N P Kriek; A Michel; D F Keet; J P Raath; H F Huchzermeyer
Journal:  Onderstepoort J Vet Res       Date:  2001-06       Impact factor: 1.792

7.  Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis.

Authors:  Vasan K Sambandamurthy; William R Jacobs
Journal:  Microbes Infect       Date:  2005-05       Impact factor: 2.700

8.  A serosurvey of viral infections in lions (Panthera leo), from Queen Elizabeth National Park, Uganda.

Authors:  Margaret Driciru; Ludwig Siefert; Katherine C Prager; Edward Dubovi; Robert Sande; Frank Princee; Tom Friday; Linda Munson
Journal:  J Wildl Dis       Date:  2006-07       Impact factor: 1.535

9.  Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovis.

Authors:  Konstantin Lyashchenko; Adam O Whelan; Rena Greenwald; John M Pollock; Peter Andersen; R Glyn Hewinson; H Martin Vordermeier
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.

Authors:  Vasan K Sambandamurthy; Xiaojuan Wang; Bing Chen; Robert G Russell; Steven Derrick; Frank M Collins; Sheldon L Morris; William R Jacobs
Journal:  Nat Med       Date:  2002-09-09       Impact factor: 53.440
View more
  5 in total

1.  A neonatal oral Mycobacterium tuberculosis-SIV prime / intramuscular MVA-SIV boost combination vaccine induces both SIV and Mtb-specific immune responses in infant macaques.

Authors:  Kara Jensen; Myra Grace Dela Pena; Robert L Wilson; Uma Devi K Ranganathan; William R Jacobs; Glenn Fennelly; Michelle Larsen; Koen K A Van Rompay; Pamela A Kozlowski; Kristina Abel
Journal:  Trials Vaccinol       Date:  2013-11-01

Review 2.  Gene Transfer in Mycobacterium tuberculosis: Shuttle Phasmids to Enlightenment.

Authors:  William R Jacobs
Journal:  Microbiol Spectr       Date:  2014-04

Review 3.  Vaccine development for tuberculosis: current progress.

Authors:  Ian M Orme
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

4.  A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques.

Authors:  Kara Jensen; Uma Devi K Ranganathan; Koen K A Van Rompay; Don R Canfield; Imran Khan; Resmi Ravindran; Paul A Luciw; William R Jacobs; Glenn Fennelly; Michelle H Larsen; Kristina Abel
Journal:  Clin Vaccine Immunol       Date:  2012-06-13

5.  Mycobacterium bovis infection in humans and cats in same household, Texas, USA, 2012.

Authors:  Kira E F Ramdas; Konstantin P Lyashchenko; Rena Greenwald; Suelee Robbe-Austerman; Cynthia McManis; W Ray Waters
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.